Aminolevulinic Acid Hydrochloride

盐酸氨基戊酮酸

Report date: 2026/04/23 20:00:25
NMEFirst In Class

Base Information

Drug NameAminolevulinic Acid Hydrochloride
Drug Alias Name氨基乙酰丙酸盐酸盐ALA HClALA-PDT盐酸氨基乙酰丙酸盐酸氨酮戊酸 +[25
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhotosensitizers
TargetsNot applicable
Therapy Area/IndicationsContrast agentsSquamous Intraepithelial LesionsGraft vs Host Disease +[40
Global Approved IndicationsContrast agentsKeratosis, ActinicGlioma +[4
Approved Indications in ChinaCondylomata Acuminata
Original Approved Country/TerritoryUnited States
Original Approved Date1999/12/03
Country/TerritoryUnited StatesNorwayAustria +[10
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDusa Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active IndicationsContrast agentsGraft vs Host DiseaseSunburn +[21
Inactive IndicationsSquamous Intraepithelial LesionsDermatitis, SeborrheicColitis, Ulcerative +[19

Other Information

ATC CodeL01XD04